Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and

Bernhard Rauch1,2, Annett Salzwedel3, Birna Bjarnason-Wehrens4

  • 1Institut für Herzinfarktforschung Ludwigshafen, D-67063 Ludwigshafen, Germany.

Insights

Cardiovascular rehabilitation (CR) significantly reduces mortality post-ACS and CABG. While beneficial for heart failure patients, CR effectiveness varies, highlighting the need for standardized delivery and further research.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Public Health

Background:

  • Cardiovascular rehabilitation (CR) attendance and delivery vary across Europe.
  • Prognostic effects of CR are not well-established for all cardiovascular diseases.

Purpose of the Study:

  • To provide guidelines on CR indications, content, and delivery.
  • To evaluate the prognostic effect of CR in specific patient groups.
  • To assess the impact of psychological interventions within CR.

Main Methods:

  • Guidelines developed with external supervision from AWMF.
  • Four meta-analyses conducted for acute coronary syndrome (ACS), coronary bypass grafting (CABG), heart failure with reduced ejection fraction (HFrEF), and psychological interventions.
  • Literature search and formal consenting process for other indications.

Main Results:

  • Multidisciplinary CR significantly reduces mortality in ACS and CABG patients.
  • HFrEF patients show improved exercise capacity and quality of life with CR.
  • CR benefits extend to other cardiovascular diseases, though evidence is less clear.
  • Treatment intensity, including supervision and exercise, is crucial for CR effectiveness.

Conclusions:

  • CR offers substantial benefits for specific cardiovascular conditions.
  • Deficits in CR delivery and research methodology persist.
  • Guidelines aim to improve CR practice and scientific rigor.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
82
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
98
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
178
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
69